Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations, contribution to normal fat metabolism, increase in the intestinal absorption of glutamine, faster recovery from muscle fatigue after exercise, improvement of neuromuscular function, contribution to normal cognitive function and maintenance of normal neurological function. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is lecithin/phospatidyl choline. The Panel considers that, whereas lecithin preparations or phosphatidyl choline from unspecified sources are not sufficiently characterised, the food constituent, soy phosphatidyl choline, which the Panel assumes to be the subject of the health claims, is sufficiently characterised.